Press release
Obesity Treatment Market Size to Boost USD 38.00 Billion By 2032 | CAGR 10.0% - Published by Emergen Research
Obesity Treatment Market
The obesity treatment market represents a critical sector within the healthcare industry, addressing the multifaceted challenge of obesity and its associated health complications. Obesity, characterized by excessive accumulation of body fat, has reached epidemic proportions globally, posing significant health risks and economic burdens. The obesity treatment market encompasses various interventions, including lifestyle modifications, pharmacotherapy, bariatric surgery, and emerging therapies, aimed at managing weight, improving metabolic health, and reducing obesity-related comorbidities.
The report offers these individuals a vivid description of the competitive spectrum of the global Obesity Treatment Market The study audits various winning strategies adopted by the market leaders to maintain the competitive edge worldwide. This adds more clarity to the research. Resource charts, tables and graphical images are included to make decisive statistics self-explanatory.
Request Free Sample Copy (To Understand the Complete Structure of this Report [Summary + TOC]) @ https://www.emergenresearch.com/request-sample/2775
Drivers of the Obesity Treatment Market :
Several factors are driving the growth of the obesity treatment market. Firstly, the rising prevalence of obesity worldwide, fueled by factors such as sedentary lifestyles, unhealthy dietary habits, and genetic predisposition, underscores the urgent need for effective treatment options. As obesity rates continue to climb, healthcare systems are under pressure to address the growing burden of obesity-related diseases, driving demand for obesity management strategies and interventions.
Challenges and Restraints
Despite the growth potential, the obesity treatment market faces several challenges and restraints. One of the primary challenges is the complex nature of obesity, which requires a multifaceted approach to treatment addressing behavioral, metabolic, and environmental factors. Achieving sustainable weight loss and long-term management of obesity can be challenging, leading to high rates of treatment failure and patient relapse.Moreover, stigma and discrimination surrounding obesity persist, impacting access to care, treatment adherence, and patient outcomes. Healthcare providers and policymakers must address biases and misconceptions about obesity to ensure equitable access to treatment and support for individuals living with obesity.
Emergen Research is Offering Limited Time Discount (Grab a Copy at Discounted Price Now) @ https://www.emergenresearch.com/request-discount/2775
The report also discusses the key players involved in the market such as:
Novo Nordisk, Roche, Eli Lilly and Company, GlaxoSmithKline (GSK), AstraZeneca, Johnson & Johnson, Sanofi, Allergan, Medtronic, Orexigen Therapeutics, Arena Pharmaceuticals, Vivus, Eisai, Takeda Pharmaceuticals, Boehringer Ingelheim, Rhythm Pharmaceuticals, Zafgen, Gelesis, Intarcia Therapeutics, and Nalpropion Pharmaceuticals
The report provides a thorough estimation of the overall impact of the pandemic on the Obesity Treatment Market and its vital segments. The report also discusses the impact of the pandemic across different regions of the market. It also offers a current and future assessment of the impact of the pandemic on the Obesity Treatment Market
Obesity Treatment Latest Industry Updates
In August, 2023, Novo Nordisk reported positive results from the SELECT trial, revealing that semaglutide 2.4 mg reduces major adverse cardiovascular events (MACE) by 20% in adults with overweight or obesity and established cardiovascular disease. The trial enrolled 17,604 adults, demonstrating statistically significant MACE reduction, with a well-tolerated profile. Semaglutide 2.4 mg, marketed as Wegovy, aims to revolutionize obesity treatment by offering effective weight management while lowering cardiovascular risks.
In September 2021, Allergan Plc (AbbVie) announced that the US Food and Drug Administration (FDA) approved its once-weekly GLP-1 receptor agonist, semaglutide, for the treatment of obesity to give patients with obesity and related conditions, such as type 2 diabetes, a new treatment option.
Direct Order Can Be Placed Through This Link [Exclusive Copy] @ https://www.emergenresearch.com/select-license/2775
Obesity Treatment Market Segment Analysis :
For the purpose of this report, Emergen Research has segmented the global obesity treatment market on the basis of treatment type, end-use, technology, cause, and region:
Treatment Type Outlook (Revenue, USD Billion; 2019-2032)
Pharmaceuticals
Prescription Drugs (e.g., Orlistat, Liraglutide)
Over-the-Counter (OTC) Drugs
Surgical Procedures:
Bariatric Surgery (e.g., Gastric Bypass, Sleeve Gastrectomy)
Liposuction
Dietary and Lifestyle Interventions:
Diet Plans and Programs
Physical Activity and Exercise Programs
Behavioral Therapy
End-Use Outlook (Revenue, USD Billion; 2019-2032)
Hospitals and Clinics
Pharmacies:
Retail Pharmacies
Online Pharmacies
Fitness and Wellness Centers
Research and Academic Institutes
Technology Outlook (Revenue, USD Billion; 2019-2032)
Drug Delivery Technologies
Minimally Invasive Surgical Technologies
Telehealth and Digital Health Solutions
Cause Outlook (Revenue, USD Billion; 2019-2032)
Genetic Obesity
Diet-Induced Obesity
Lifestyle-Related Obesity
Regional Outlook (Revenue, USD Billion; 2019-2032)
North America
U.S.
Canada
Mexico
Europe
Germany
France
UK
Italy
Spain
Benelux
Rest of Europe
Asia Pacific
China
India
Japan
South Korea
Rest of APAC
Latin America
Brazil
Rest of LATAM
Middle East & Africa
Saudi Arabia
UAE
South Africa
Turkey
Rest of Middle East & Africa
Browse Full Report Description + Research Methodology + Table of Content + Infographics @ https://www.emergenresearch.com/industry-report/obesity-treatment-market
Contact Us:
Eric Lee
Corporate Sales Specialist
Emergen Research
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com
Visit for More Insights: https://www.emergenresearch.com/insights
Contact Us:
Eric Lee
Corporate Sales Specialist
Emergen Research
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com
Visit for More Insights: https://www.emergenresearch.com/insights
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Obesity Treatment Market Size to Boost USD 38.00 Billion By 2032 | CAGR 10.0% - Published by Emergen Research here
News-ID: 3472678 • Views: …
More Releases from Emergen Research
Global Internet of Things (IoT) in Healthcare Market to Reach USD 299.05 Billion …
The global Internet of Things (IoT) in Healthcare Market was valued at USD 299.05 billion in 2023 and is expected to grow at a CAGR of 16.5% during the forecast period. This growth is fueled by the rising use of connected healthcare devices, increasing demand for early disease detection through remote monitoring, and growing adoption of artificial intelligence (AI) tools within IoT-based healthcare systems.
The market is also benefiting from the…
Global Stem Cell Therapy Market to Reach USD 49.2 Billion by 2034, Growing at 13 …
The global Stem Cell Therapy Market, valued at USD 13.7 billion in 2024, is projected to reach USD 49.2 billion by 2034, expanding at a compound annual growth rate (CAGR) of 13.6%. Growth is being fueled by the rising burden of chronic diseases, rapid progress in cell-based studies, and increasing investments in regenerative medicine and personalized healthcare solutions.
Stem cell therapies offer the ability to repair, replace, or restore damaged tissues…
Artificial Intelligence Strengthens Cybersecurity as Threats Grow More Sophistic …
The global Artificial Intelligence in cybersecurity market size was USD 23.8 Billion in 2023 and is expected to reach a market valuation of USD 29.44 billion by the end of 2024 registering a CAGR of 23.7% during the forecast period. The adoption of Artificial Intelligence (AI) in cybersecurity is rapidly gaining traction as organizations worldwide face increasingly complex and frequent cyber threats. By combining advanced technologies such as Machine Learning…
Global Regenerative Medicine Market to Reach USD 125.6 Billion by 2034, Growing …
The global regenerative medicine market, valued at USD 34.2 billion in 2024, is set to grow to USD 125.6 billion by 2034, expanding at a compound annual growth rate (CAGR) of 13.9%. Growth is being fueled by rising approvals of advanced therapies, strong demand for personalized treatments in cancer and orthopedics, and expanding cell and gene therapy manufacturing across major markets such as North America, Europe, and Asia.
Once seen as…
More Releases for Obesity
Anti-Obesity Drugs Market Grows Rapidly, Driven by Obesity Rates and Therapeutic …
Anti-Obesity Drugs Market valued at USD 5.9 Bn in 2024, growing at 16.5% CAGR to reach USD 20.02 Bn by 2032. Driven by GLP-1 therapies and rising obesity rates.
Anti Obesity Drugs Market Overview:
The anti-obesity drugs market is undergoing significant transformation as awareness about obesity-related health risks rises globally. With growing concern over lifestyle-related disorders, there is an increasing emphasis on medical intervention as a complement to traditional weight management strategies.…
Fuzzle joins The Obesity Society & The Obesity Action Coalition; Promotes Habit- …
Building healthy, sustainable habits for long-term weight management success.
Tampa, FL - March 18, 2025 - Fuzzle, an emerging leader in the wellness landscape, is pleased to announce that it's now a Member of The Obesity Society, as well as the Obesity Action Coalition, marking a new milestone in the company's mission to transform how individuals approach weight loss.
Image: https://www.globalnewslines.com/uploads/2025/03/77da787ae98a633847c70fc22e2943c7.jpg
Fuzzle supports individuals in their wellness journey through non-invasive, drug-free strategies. With…
Pediatric Obesity Management Market - Healthy Habits for Life: Advancing Pediatr …
Newark, New Castle, USA: The "Pediatric Obesity Management Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors.
Pediatric Obesity Management Market: https://www.growthplusreports.com/report/pediatric-obesity-management-market/8930
This latest report researches the industry structure,…
Anti-Obesity Drugs Market - From Obesity to Vitality: Leading the Way in Effecti …
Newark, New Castle, USA - new report, titled Anti-Obesity Drugs Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Anti-Obesity Drugs market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Anti-Obesity Drugs market. The report offers an overview of the market, which…
Increasing Prevalence of Obesity Driving Obesity/Bariatric Surgery Devices Marke …
The global obesity/bariatric surgery devices market revenue stood at $1.4 billion in 2016, and it is expected to rise to $2.8 billion by 2023. Furthermore, the market will progress at a CAGR of 9.9% from 2017 to 2023 (forecast period), as per the estimates of the market research company, P&S Intelligence. The major growth drivers of the market are the rising incidence of obesity, owing to unhealthy diets and lifestyle…
Fast Food and Obesity
Most of the fast food in the market contains a large quantity of sugar, #carbs and fats with a lesser quantity of vitamins and minerals. The unhealthy food ingredients in the fast food are further increased with increased portion size. The person will still consume the whole meal regardless of being completely full. People cannot stop ravishing on fast food because it is available for low cost and in close…
